180 related articles for article (PubMed ID: 24728517)
1. Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome?
Feist M; Huang X; Müller JM; Rau B; Dubiel W
Int J Colorectal Dis; 2014 Jun; 29(6):673-80. PubMed ID: 24728517
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional fine-tuning of COP9 signalosome subunit biosynthesis is regulated by the c-Myc/Lin28B/let-7 pathway.
Leppert U; Henke W; Huang X; Müller JM; Dubiel W
J Mol Biol; 2011 Jun; 409(5):710-21. PubMed ID: 21530537
[TBL] [Abstract][Full Text] [Related]
3. Novel curcumin- and emodin-related compounds identified by in silico 2D/3D conformer screening induce apoptosis in tumor cells.
Füllbeck M; Huang X; Dumdey R; Frommel C; Dubiel W; Preissner R
BMC Cancer; 2005 Aug; 5():97. PubMed ID: 16083495
[TBL] [Abstract][Full Text] [Related]
4. The CSN/COP9 signalosome regulates synaptonemal complex assembly during meiotic prophase I of Caenorhabditis elegans.
Brockway H; Balukoff N; Dean M; Alleva B; Smolikove S
PLoS Genet; 2014 Nov; 10(11):e1004757. PubMed ID: 25375142
[TBL] [Abstract][Full Text] [Related]
5. COP9 signalosome function in the DDR.
Hannss R; Dubiel W
FEBS Lett; 2011 Sep; 585(18):2845-52. PubMed ID: 21510940
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.
Peth A; Berndt C; Henke W; Dubiel W
BMC Biochem; 2007 Dec; 8():27. PubMed ID: 18093314
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome.
Uhle S; Medalia O; Waldron R; Dumdey R; Henklein P; Bech-Otschir D; Huang X; Berse M; Sperling J; Schade R; Dubiel W
EMBO J; 2003 Mar; 22(6):1302-12. PubMed ID: 12628923
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
9. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
[TBL] [Abstract][Full Text] [Related]
10. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.
Helderman RFCPA; Löke DR; Verhoeff J; Rodermond HM; van Bochove GGW; Boon M; van Kesteren S; Garcia Vallejo JJ; Kok HP; Tanis PJ; Franken NAP; Crezee J; Oei AL
Cells; 2020 Jul; 9(8):. PubMed ID: 32722384
[TBL] [Abstract][Full Text] [Related]
11. Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer.
Woeste MR; Philips P; Egger ME; Scoggins CR; McMasters KM; Martin RCG
J Surg Oncol; 2020 Jun; 121(8):1298-1305. PubMed ID: 32239529
[TBL] [Abstract][Full Text] [Related]
12. Pancytopenia after administration of hyperthermic intraperitoneal chemotherapy with mitomycin-C: local therapy and systemic toxicity.
Wu V; Shen J; Chung SY; Saif MW
Anticancer Drugs; 2021 Sep; 32(8):894-896. PubMed ID: 34145180
[TBL] [Abstract][Full Text] [Related]
13. Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1.
Sun Y; Wilson MP; Majerus PW
J Biol Chem; 2002 Nov; 277(48):45759-64. PubMed ID: 12324474
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.
Weng SH; Tsai MS; Chiu YF; Kuo YH; Chen HJ; Lin YW
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):298-306. PubMed ID: 21973306
[TBL] [Abstract][Full Text] [Related]
15. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
16. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
van Eden WJ; Kok NFM; Woensdregt K; Huitema ADR; Boot H; Aalbers AGJ
Eur J Surg Oncol; 2018 Feb; 44(2):220-227. PubMed ID: 29258720
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.
Kemmel V; Mercoli HA; Meyer N; Brumaru D; Romain B; Lessinger JM; Brigand C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S873-9. PubMed ID: 26100819
[TBL] [Abstract][Full Text] [Related]
18. UV-dependent phosphorylation of COP9/signalosome in UV-induced apoptosis.
Dubois EL; Gerber S; Kisselev A; Harel-Bellan A; Groisman R
Oncol Rep; 2016 May; 35(5):3101-5. PubMed ID: 26986008
[TBL] [Abstract][Full Text] [Related]
19. Roles of COP9 signalosome in cancer.
Lee MH; Zhao R; Phan L; Yeung SC
Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
[TBL] [Abstract][Full Text] [Related]
20. Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival.
Kwakman R; de Cuba EM; de Winter JP; de Hingh IH; Delis-van Diemen PM; Tijssen M; Rooimans MA; Krijgsman O; Carvalho B; Peters GJ; Bonjer HJ; Meijer GA; Te Velde EA
Br J Cancer; 2015 Mar; 112(5):851-6. PubMed ID: 25668003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
